Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTC4IMS)

DTT Name	NKG2-A/B-activating NK receptor (NKG2A) DTT Info
Gene Name	KLRC1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Preclinical Drug(s)

Download the Complete Related Drug List

3 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
NN8765	DMCFPBE	Rheumatoid arthritis	FA20	Phase 2	[1]
BMS-986315	DMTEY1L	Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[2]
Monalizumab	DMG7XHE	Chronic lymphocytic leukaemia	2A82.0	Phase 1/2	[3]
------------------------------------------------------------------------------------

1 Preclinical Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
IM1240	DMTV0DK	Aggressive cancer	2A00-2F9Z	Preclinical	[4]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Handbook of Therapeutic Antibodies. 2014. 1. Page(1098).
2	ClinicalTrials.gov (NCT04349267) Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors. U.S. National Institutes of Health.
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4	Clinical pipeline report, company report or official report of Purple